Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$30.32 - $91.33 $67,916 - $204,579
-2,240 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$86.26 - $119.0 $10,955 - $15,113
-127 Reduced 5.37%
2,240 $209,000
Q3 2021

Nov 08, 2021

BUY
$100.17 - $126.36 $237,102 - $299,094
2,367 New
2,367 $264,000
Q2 2021

Aug 05, 2021

SELL
$86.05 - $119.72 $1.47 Million - $2.05 Million
-17,139 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$91.47 - $124.36 $1.58 Million - $2.15 Million
-17,292 Reduced 50.22%
17,139 $1.74 Million
Q4 2020

Feb 04, 2021

SELL
$66.66 - $111.74 $97,656 - $163,699
-1,465 Reduced 4.08%
34,431 $3.43 Million
Q3 2020

Nov 02, 2020

BUY
$45.89 - $72.67 $508,461 - $805,183
11,080 Added 44.65%
35,896 $2.59 Million
Q2 2020

Aug 05, 2020

BUY
$26.36 - $49.86 $85,406 - $161,546
3,240 Added 15.02%
24,816 $1.24 Million
Q1 2020

May 04, 2020

BUY
$17.27 - $40.17 $41,672 - $96,930
2,413 Added 12.59%
21,576 $644,000
Q4 2019

Feb 07, 2020

SELL
$32.1 - $40.4 $1,123 - $1,414
-35 Reduced 0.18%
19,163 $646,000
Q3 2019

Nov 07, 2019

BUY
$25.38 - $34.89 $231,719 - $318,545
9,130 Added 90.68%
19,198 $630,000
Q2 2019

Jul 29, 2019

BUY
$17.75 - $27.58 $178,707 - $277,675
10,068 New
10,068 $278,000
Q3 2018

Nov 05, 2018

SELL
$18.82 - $28.96 $814,717 - $1.25 Million
-43,290 Closed
0 $0
Q2 2018

Jul 31, 2018

BUY
$8.79 - $19.98 $380,519 - $864,934
43,290 New
43,290 $815,000
Q4 2017

Feb 05, 2018

SELL
$8.99 - $14.31 $241,201 - $383,937
-26,830 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$8.02 - $13.33 $103,778 - $172,490
12,940 Added 93.16%
26,830 $346,000
Q2 2017

Aug 09, 2017

BUY
N/A
13,890
13,890 $151,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.